Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Emmecell logo — Magnetic Cell Delivery Platform for Cell Therapy

Emmecell

Magnetic Cell Delivery Platform for Cell Therapy

United States Menlo Park, United States 11 employees Biotechnology, Health Care

General Information

Company Name Emmecell
Location United States Menlo Park, United States
Employees 11
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Emmecell. To contact Emmecell, visit emmecell.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Emmecell compare?

A PDF of Emmecell and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Emmecell soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Emmecell

Emmecell, a privately-held, clinical stage biotechnology company, is gaining attention in the field of cell-based therapies with their innovative magnetic cell delivery platform. Their lead product, EO2002, is designed to tackle corneal edema, a prevalent indication for corneal transplantation. By leveraging magnetic nanoparticles, Emmecell aims to improve the localization and integration of cell therapies into the target tissue, thus presenting a promising solution to a common healthcare challenge. In 2018, Emmecell expanded its reach with the establishment of Cell Manufacturing and Production LLC (CellMP), a subsidiary offering GMP manufacturing services in Menlo Park, CA. This strategic move not only enhances the company's capabilities but also positions them for potential growth in the biotechnology and healthcare industries. Although no recent investment details are available, Emmecell's focus on advancing cell-based therapies and strengthening their manufacturing capabilities demonstrates a forward-looking approach. Considering their pioneering technology and potential to address unmet medical needs, Emmecell presents an intriguing opportunity for venture capital firms seeking to invest in innovative biotechnology ventures.

Business keywords: Ophthalmology, Cell Therapy, Nanotechnology, Magnetic Cell Delivery, Clinical Trials, cGMP Manufacturing

No funding data available for Emmecell yet.

Emmecell Alternatives & Competitors

View All Alternatives
Emmecell vs
MICA Biosystems
MICA Biosystems United Kingdom

An innovative and dynamic biotech start-up, unlocking the potential of stem cells and nanotechnology...

Grant
9 employees
Biotechnology, Health Care
Emmecell vs
Cognate BioServices, a Charles River Company
Cognate BioServices, a Charles River Company United States

Your CDMO Partner from Concept to Commercial for Cell & Gene Therapy Products

Series B
81 employees
Biotechnology, Health Care
Emmecell vs
Stemedica Cell Technologies, Inc
Stemedica Cell Technologies, Inc United States

Developing Breakthrough Progenitor Cell and Protein Therapeutics

Series B
16 employees
Biotechnology, Health Care
Also compare with: Emmecell vs Aurion Biotech Aurion Biotech View all alternatives

FAQ About Emmecell

Magnetic Cell Delivery Platform for Cell Therapy
Emmecell is headquartered in Menlo Park, United States.
Emmecell operates in Biotechnology and Health Care. Its work centres on Ophthalmology, Cell Therapy, Nanotechnology and Magnetic Cell Delivery.
Emmecell has approximately 11 employees.
Top alternatives and competitors to Emmecell include MICA Biosystems, Cognate BioServices, a Charles River Company, Stemedica Cell Technologies, Inc, Aurion Biotech, Waisman Biomanufacturing. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Emmecell and MICA Biosystems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Emmecell, https://bouncewatch.com/company/emmecell, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes